|
AU2017318591A1
|
|
Bendamustine solution formulations
|
|
EP3153162A1
|
|
Preparation of pharmaceutical dosage forms containing iron (iii) salts
|
|
JP2016222667A
|
|
Crystalline fosaprepitant dicyclohexylamine salt and its preparation
|
|
EP3031800A1
|
|
Process for the preparation of high purity miglustat
|
|
EP2777696A1
|
|
Preparation of stable pharmaceutical dosage forms
|
|
WO2013070656A1
|
|
Sustained release suspension preparation for dextromethorphan
|
|
CA2767708A1
|
|
Cross-linked polyallylamine tablet core
|
|
WO2010065706A1
|
|
Manufacturing process of making polymeric amine salts
|
|
EP2265597A2
|
|
Concentrated aqueous and/or ethanolic solution of 4-methylpyrazole (fomepizole)
|
|
EP2268827A1
|
|
Process of making optically pure melphalan
|
|
US2009111871A1
|
|
Felbamate with improved bulk density
|
|
US2008125595A1
|
|
Processes of manufacturing substituted-1,4-dihydropyridines, improved aqueous solutions thereof, and processes of manufacturing the solutions
|
|
US2006276654A1
|
|
Process of making optically pure L-pipecolic acid and process of making anesthetics and intermediates therefrom
|
|
US2007129546A1
|
|
Manufacture of pure hydralazine salts
|
|
US2007104763A1
|
|
Composition of fentanyl citrate oral solid transmucosal dosage form, excipient and binding material therefore, and methods of making
|
|
US2007004805A1
|
|
Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate
|
|
US2006270708A1
|
|
Novel process for preparation of isotonic aqueous injection of ropivacaine
|
|
EP1733058A2
|
|
Iron sucrose complexes and method of manufacture thereof
|
|
WO2005094203A2
|
|
Sodium ferric gluconate complexes and method of manufacture thereof
|
